Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2013

View Archived Issues

AN-162 shows potent inhibitory effects in prostate cancer models

Flexible dosing of insulin degludec achieves glycemic control

Safety, tolerability and pharmacokinetics of ONO-9054 reported

A novel Neto1-KO mouse model with schizophrenia-related behavioral phenotype

Fourth pivotal trial of Celgene's apremilast in psoriatic arthritis meets endpoints

Biomarker modulation seen in phase I trial of AZD-1208

Novel Youai compounds active against RAS-mutant cancers

Lundbeck updates accomplishments of first quarter 2013

Calithera Biosciences targets GLS with novel compounds

Novel kappa opioid receptor agonist shows promise in animal models of dermatitis

Novo Nordisk recaps progress of first quarter 2013

Nimbus Discovery and Shire to codevelop treatments for lysosomal storage disorders

Data monitoring committee recommends continuation of phase III GRIPHON study

GSK updates on plans to share detailed clinical trial data

Zhejiang Huahai and Oncobiologics sign alliance for biosimilar monoclonal antibodies

Investigator initiated study in triple-negative breast cancer starts in Japan

Array BioPharma patents new tyrosine-protein kinase inhibitors

Portola's PRT-4445 shown to reverse anticoagulant activity of Eliquis in phase II study

Concordia Pharmaceuticals acquires the rights to Shionogi products

Celsus reports interim data from phase II contact dermatitis study

Techulon receives DARPA contract for therapies aimed at multi-drug resistant bacteria

Boehringer Ingelheim joins Structural Genomics Consortium on drug discovery projects

Abbott obtains CE Mark for diabetes diagnostic

Aviir launches cardiovascular genetic testing services

OMI obtains grants for myalgic encephalomyelitis/chronic fatigue syndrome

Inovio Pharmaceuticals discloses novel DNA vaccines for arenavirus

New beta-lactamase inhibitors synthesized by Therabor Pharmaceuticals

Aileron Therapeutics creates HIF-inhibiting Stapled Peptide for cancer therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...